ロード中...
Drugs Involved in Dyslipidemia and Obesity Treatment: Focus on Adipose Tissue
Metabolic syndrome can be defined as a state of disturbed metabolic homeostasis characterized by visceral obesity, atherogenic dyslipidemia, arterial hypertension, and insulin resistance. The growing prevalence of metabolic syndrome will certainly contribute to the burden of cardiovascular disease....
保存先:
| 出版年: | Int J Endocrinol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5822899/ https://ncbi.nlm.nih.gov/pubmed/29593789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/2637418 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|